| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Selling, general and administrative | $4.6M+0.3% | $4.6M-50.0% | $9.3M-24.1% | $12.2M-21.7% | $15.6M-0.5% | $15.7M |
| Total operating expenses | $4.6M+0.3% | $4.6M-74.0% | $17.8M-24.6% | $23.6M-2.6% | $24.3M+6.4% | $22.8M |
| Loss from continuing operations | -$4.6M-0.3% | -$4.6M+66.0% | -$13.6M+31.6% | -$19.9M-10.3% | -$18.0M-4.4% | -$17.3M |
| Warrant issuance costs | -$10.4M | — | — | — | — | — |
| Change in fair value of derivative liability | $3.5M | — | $2.6M+463.0% | $460K-95.1% | $9.4M+661.3% | -$1.7M |
| Change in fair value of warrant liability | $10.3M | — | — | — | — | — |
| Interest income | $257K-30.9% | $372K-27.9% | $515K+3530.5% | $14K | — | — |
| Total other income, net | $141K-96.4% | $3.9M-28.1% | $5.5M+4577.1% | -$122K | — | — |
| Loss before income taxes | -$4.5M-538.1% | -$705K+91.4% | -$8.2M+59.3% | -$20.0M | — | -$22.0M |
| Provision for income taxes | $0 | $0 | $0 | — | — | -$1.4M |
| Loss from continuing operations, net of tax | -$4.5M-538.1% | -$705K | — | — | — | — |
| Gain from assignment of subsidiaries and Vivus settlement | $7.0M | — | — | — | — | — |
| Less loss from discontinued operations | -$560K+95.9% | -$13.6M | — | — | — | — |
| Net income (loss) | $1.9M+113.4% | -$14.3M-75.4% | -$8.2M+59.3% | -$20.0M-123.0% | -$9.0M+56.3% | -$20.6M |
| Preferred stock dividend and cash premiums | -$974K+57.8% | -$2.3M-181.0% | -$821K | — | — | — |
| Preferred stock accretion | $0+100.0% | -$10.2M-110.6% | -$4.8M | — | — | — |
| Net loss from continuing operations attributable to common stockholders | -$50.1M-280.0% | -$13.2M | — | — | — | — |
| Gain (loss) from discontinued operations attributable to common stockholders | $6.4M+147.1% | -$13.6M | — | — | — | — |
| Basic - continuing operations (in dollars per share) | -$1.79+95.6% | -$41.06 | — | — | — | — |
| Diluted - continuing operations (in dollars per share) | -$1.79+95.6% | -$41.06 | — | — | — | — |
| Basic - discontinued operations, assignment and settlement | $0.23+100.5% | -$42.4 | — | — | — | — |
| Diluted - discontinued operations, assignment and settlement | $0.23+100.5% | -$42.4 | — | — | — | — |
| Basic (in dollars per share) | -$1.56+98.1% | -$83.47-1214.5% | -$6.35+34.4% | -$9.68-17.3% | -$8.25-114.3% | -$3.85 |
| Diluted (in dollars per share) | -$1.56+98.1% | -$83.47-1214.5% | -$6.35+34.4% | -$9.68-17.3% | -$8.25-114.3% | -$3.85 |
| Basic (in shares) | 28.1M+8642.0% | 321K-85.2% | 2.2M+5.1% | 2.1M+90.1% | 1.1M-79.6% | 5.3M |
| Diluted (in shares) | 28.1M+8642.0% | 321K-85.2% | 2.2M+5.1% | 2.1M+90.1% | 1.1M-79.6% | 5.3M |
| Series A Preferred Warrants | ||||||
| Deemed dividend on Warrants | -$3.0M | — | — | — | — | — |
| Series A Warrants | ||||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.